Association of Ki-67 Labelling Index and IL-17A with Pituitary Adenoma

Table 7

Serum levels of IL-17A in patients with pituitary adenoma and in controls considering growth type of pituitary adenoma.

PA growth type	Group (n)	IL-17A concentration (pg/mL); min/median/max	p value
Invasiveness	Invasive (29)	1.95/42.12/76.80	p = 0.701
	Noninvasive (25)	3.10/42.12/76.80
Recurrence	Recurrent PA (5)	1.95/42.12/76.80	p = 0.664
	Nonrecurrent PA (49)	3.10/42.12/76.80
Suprasellar growth	Yes (38)	1.95/42.12/76.80	p = 0.234
	No (16)	4.29/39.95/55.12
Paracavernous growth	Yes (18)	1.95/44.29 /76.80	p = 0.281
	No (36)	3.10/41.04/76.80
Parasphenoidal growth	Yes (24)	1.95/42.12/76.80	p = 0.700
	No (30)	3.10/42.12/76.80

:Mann-Whitney U test; IL-17A: interleukin-17A.